ConductScience.org, home

Paper39636147

Diversity in chemotherapy-induced cachexia.

Novinger LJ and 2 others. Am J Physiol Cell Physiol, 2025. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Diversity in chemotherapy-induced cachexia. Papers, record 39636147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39636147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diversity in chemotherapy-induced cachexia.
PubMed
Journal
Am J Physiol Cell Physiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
3.81, provisional
iCite
Revised in PubMed
2026-06-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Novinger LJLeah J
2Weinzierl NMNatalia M
3Bonetto AAndreahttps://orcid.org/0000-0002-3235-1871

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CachexiaMajor topic
NeoplasmsMajor topic
Animals
Female
Humans
Male
Age Factors
Muscle, Skeletal
Muscular Atrophy
Sex Factors

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AR080051NIAMS NIH HHSUnited StatesR01AR080051PubMed and NIHNIH RePORTER
P50 CA261605NCI NIH HHSUnited StatesP50CA261605PubMed and NIHNIH RePORTER
R01 AR079379NIAMS NIH HHSUnited StatesR01AR079379PubMed and NIHNIH RePORTER
R01AR080051HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)R01AR080051PubMed and NIHNIH RePORTER
P50CA261605HHS | NIH | National Cancer Institute (NCI)P50CA261605PubMed and NIHNIH RePORTER
R01AR079379HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)R01AR079379PubMed and NIHNIH RePORTER

Download CSV of grants

References85

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130144305Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients.J Cachexia Sarcopenia Muscle2018https://conductscience.org/library/papers/30144305PubMed
228850803High Serum Essential Amino Acids as a Predictor of Skeletal Muscle Depletion in Patients With Cachexia and Advanced Gastrointestinal Cancers.Nutr Clin Pract2017https://conductscience.org/library/papers/28850803PubMed
337017344GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice.J Cachexia Sarcopenia Muscle2023https://conductscience.org/library/papers/37017344PubMed
424415363Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.Head Neck2015https://conductscience.org/library/papers/24415363PubMed
538519312Sarcopenia with decreased total psoas muscle area in children with high-risk neuroblastoma.Asian J Surg2024https://conductscience.org/library/papers/38519312PubMed
637902220Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy.Cancer Med2023https://conductscience.org/library/papers/37902220PubMed
726903572Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.J Clin Oncol2016https://conductscience.org/library/papers/26903572PubMed
829089584ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.Sci Rep2017https://conductscience.org/library/papers/29089584PubMed
934664403Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice.J Cachexia Sarcopenia Muscle2021https://conductscience.org/library/papers/34664403PubMed
1031999069Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.J Cachexia Sarcopenia Muscle2020https://conductscience.org/library/papers/31999069PubMed
1133829665Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer.Thorac Cancer2021https://conductscience.org/library/papers/33829665PubMed
1229067769Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non-small cell lung cancer.Thorac Cancer2018https://conductscience.org/library/papers/29067769PubMed
1335931609The urgent need to improve childhood cancer cachexia.Trends Cancer2022https://conductscience.org/library/papers/35931609PubMed
1436615760Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia.Nutrients2022https://conductscience.org/library/papers/36615760PubMed
1529991992Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia.Eur J Transl Myol2018https://conductscience.org/library/papers/29991992PubMed
1633067699A Retrospective Cohort Study to Investigate the Incidence of Cachexia During Chemotherapy in Patients with Colorectal Cancer.Adv Ther2020https://conductscience.org/library/papers/33067699PubMed
1727807421Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways.Front Physiol2016https://conductscience.org/library/papers/27807421PubMed
1821875767Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer.Clin Nutr2012https://conductscience.org/library/papers/21875767PubMed
1921296615Definition and classification of cancer cachexia: an international consensus.Lancet Oncol2011https://conductscience.org/library/papers/21296615PubMed
2028882973Elevated Serum AA/EPA Ratio as a Predictor of Skeletal Muscle Depletion in Cachexic Patients with Advanced Gastro-intestinal Cancers.In Vivo2017https://conductscience.org/library/papers/28882973PubMed

See all 85 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
427344275-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling.Am J Physiol Cell Physiol2026https://conductscience.org/library/papers/42734427PubMed
42286673The cGAS-STING pathway contributes to cisplatin-induced skeletal muscle atrophy through altered proteostasis and myogenic signaling.Cell Commun Signal2026https://conductscience.org/library/papers/42286673PubMed
42270763Oxaliplatin triggers adipose and muscle wasting through cancer-independent metabolic and CNS pathways in mouse models.Commun Biol2026https://conductscience.org/library/papers/42270763PubMed
41965808Prevalence of ovarian cancer cachexia in patients undergoing cytoreductive surgery at the University of Colorado between 2014-2024.J Ovarian Res2026https://conductscience.org/library/papers/41965808PubMed
41525266Sex differences in cachexia outcomes and branched-chain amino acid metabolism following chemotherapy in aged mice.PLoS One2026https://conductscience.org/library/papers/41525266PubMed
41369973The evolving landscape of cancer cachexia prevention: A review of metronomic chemotherapy and drug repurposing strategies.Med Oncol2025https://conductscience.org/library/papers/41369973PubMed
41315185Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1.Nat Commun2025https://conductscience.org/library/papers/41315185PubMed
41301412Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines.Biomolecules2025https://conductscience.org/library/papers/41301412PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39636147

GET https://conductscience.org/api/papers/v1/39636147/references?page=2